HUP0104519A2 - Eljárások antigén-szekvenciák azonosítására - Google Patents

Eljárások antigén-szekvenciák azonosítására

Info

Publication number
HUP0104519A2
HUP0104519A2 HU0104519A HUP0104519A HUP0104519A2 HU P0104519 A2 HUP0104519 A2 HU P0104519A2 HU 0104519 A HU0104519 A HU 0104519A HU P0104519 A HUP0104519 A HU P0104519A HU P0104519 A2 HUP0104519 A2 HU P0104519A2
Authority
HU
Hungary
Prior art keywords
gene sequences
subject
nucleotide sequence
methods
expression
Prior art date
Application number
HU0104519A
Other languages
English (en)
Inventor
Timothy James Duran
Robert John Moore
Original Assignee
Commonwealth Scientific And Industrial Research Organisation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific And Industrial Research Organisation filed Critical Commonwealth Scientific And Industrial Research Organisation
Publication of HUP0104519A2 publication Critical patent/HUP0104519A2/hu
Publication of HUP0104519A3 publication Critical patent/HUP0104519A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13—Labelling of peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/41—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a Myc-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/42—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a HA(hemagglutinin)-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A találmány tárgyát potenciális vakcinaantigének génszekvenciáinakazonosítására szolgáló eljárások képezik. A találmány tárgyát képeziktehát a génszekvenciák és a génszekvenciák által kódolt polipeptidek,illetve az ilyen szekvenciák alkalmazása védekező immunválaszindukálására állatokban. Konkrétan, a találmány tárgya Mycoplasma,<>előnyösen Mycoplasma hyopneumoniae potenciális antigéngénszekvenciáinak azonosítása. A találmány egy szempontja szerint a találmány tárgyát olyaneljárás képezi, amellyel expressziós vektorban lévőnukleotidszekvenciáról transzlálódott expressziós proteineket mutatunkki, és amely eljárás a nukleotidszekvenciából transzlálódott proteinés valamilyen marker együttes expressziójának alkalmazásáttartalmazza. A találmány egy másik szempontja szerint a találmánytárgya eljárás valamely betegség terápiás szempontból figyelembevehető, antigén tulajdonságú proteinjét kódoló terápiás antigéngénszekvenciájának nukleotidszekvencia-mintából történő azonosítására.A marker előnyösen poli-His-toldalék. Ó
HU0104519A 1998-11-20 1999-11-19 Methods of indentifying antigen gene sequences HUP0104519A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP7273A AUPP727398A0 (en) 1998-11-20 1998-11-20 Methods of identifying antigen gene sequences
PCT/AU1999/001035 WO2000031115A1 (en) 1998-11-20 1999-11-19 Methods of identifying antigen gene sequences

Publications (2)

Publication Number Publication Date
HUP0104519A2 true HUP0104519A2 (hu) 2002-03-28
HUP0104519A3 HUP0104519A3 (en) 2004-10-28

Family

ID=3811482

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104519A HUP0104519A3 (en) 1998-11-20 1999-11-19 Methods of indentifying antigen gene sequences

Country Status (13)

Country Link
US (1) US6759516B2 (hu)
EP (1) EP1140978A4 (hu)
JP (1) JP2002535604A (hu)
KR (1) KR100810699B1 (hu)
CN (1) CN1331699A (hu)
AU (1) AUPP727398A0 (hu)
BR (1) BR9915066A (hu)
CA (1) CA2351736A1 (hu)
HU (1) HUP0104519A3 (hu)
MX (1) MXPA01005011A (hu)
NZ (1) NZ511623A (hu)
WO (1) WO2000031115A1 (hu)
ZA (1) ZA200103677B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2436986A1 (en) * 2001-02-07 2002-08-15 Invitrogen Corporation Ter sites and ter binding proteins
SI1546357T1 (sl) 2002-06-28 2013-10-30 Iowa State University Research Foundation, Inc. Imunogeni polipeptidi mycoplasma hyopneumoniae
WO2006050571A1 (en) * 2004-11-11 2006-05-18 Queensland University Of Technology Chlamydia antigens and uses thereof
CN101851661B (zh) * 2010-05-10 2015-09-09 其昌達生物高科技(上海)有限公司 非诊断目的的在a-peg-b列阵下加快检测支原体时间的方法
WO2015123728A1 (en) * 2014-02-18 2015-08-27 University Of Technology, Sydney Mycoplasma surface proteins and uses thereof
BR102014014727B1 (pt) * 2014-06-16 2018-04-03 Ouro Fino Saúde Animal Ltda COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, GENE SINTÉTICO CODIFICANTE DO COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, COMPOSIÇÃO ANTIGÊNICA, PROCESSO DE OBTENÇÃO DE UM COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae
WO2018078167A1 (en) * 2016-10-31 2018-05-03 Universität Zürich Protein screening and detection method
CN112979769B (zh) * 2021-03-08 2023-01-31 珠海丽禾医疗诊断产品有限公司 一种氨基酸序列、蛋白质及其制备方法和应用
CN113185588A (zh) * 2021-04-28 2021-07-30 华中农业大学 一种牛支原体MbovP701蛋白及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68925769T2 (de) * 1988-06-29 1996-08-08 Ml Technology Ventures Rekombinantes hyopneumoniae Antigen und dessen Verwendung
WO1993003157A1 (en) * 1991-07-29 1993-02-18 Dana Farber Cancer Institute Plasmids for the rapid preparation of modified proteins
US5703057A (en) * 1995-04-07 1997-12-30 Board Of Regents The University Of Texas System Expression library immunization

Also Published As

Publication number Publication date
KR100810699B1 (ko) 2008-03-07
WO2000031115A1 (en) 2000-06-02
KR20010081018A (ko) 2001-08-25
HUP0104519A3 (en) 2004-10-28
US6759516B2 (en) 2004-07-06
AUPP727398A0 (en) 1998-12-17
ZA200103677B (en) 2002-05-07
BR9915066A (pt) 2002-01-15
US20020068289A1 (en) 2002-06-06
NZ511623A (en) 2003-04-29
CA2351736A1 (en) 2000-06-02
MXPA01005011A (es) 2002-04-24
CN1331699A (zh) 2002-01-16
JP2002535604A (ja) 2002-10-22
EP1140978A4 (en) 2006-03-01
EP1140978A1 (en) 2001-10-10

Similar Documents

Publication Publication Date Title
WO2002080851A3 (en) Chimeric vaccines
ATE406912T1 (de) Immunisierung gegen chlamydia tracheomatis
HUP0003601A2 (hu) HPV elleni immunválaszok kiváltása HPV-antigént és stresszproteint, vagy ezen proteineket expresszálni képes expressziós vektort tartalmazó készítményekkel
HUP0303753A2 (hu) Fúziós fehérjék immunogenitásának csökkentése
WO2002012281A3 (en) Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
BR9712852A (pt) Plasmìdeo, composição, processo de imunização de um indivìduo contra um patógeno, vacina recombinante, patógeno vivo atenuado, proteìna bl-1 substancialmente pura, vetor recombinante de expressão, e, anticorpo isolado
BR9907691A (pt) Derivados de antìgeno associado a tumor da famìlia mage, e sequências de ácido nucléico codificando os mesmos, usados para a preparação de proteìnas de fusão e de composições para vacinação
GEP20022695B (en) Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence and Uses Thereof
NZ512574A (en) Novel streptococcus antigens useful as vaccines
ATE337399T1 (de) Zusammensetzungen zur immuntherapie und diagnose von tuberculosis
HUP0105379A2 (hu) Lawsonia intracellularis elleni oltóanyag
HUP0104519A2 (hu) Eljárások antigén-szekvenciák azonosítására
NZ331989A (en) Arthritogenic peptide, DNAJ, isolated from bacterial peptides and used in vaccine compositions for treating rheumatoid arthritis
Fetterer et al. A conserved 19-kDa Eimeria tenella antigen is a profilin-like protein
ATE450545T1 (de) Impfstoff mit lawsonia intracellularis- untereinheit
HUP0300297A2 (en) Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same
CY1105947T1 (el) Νουκλεϊνικα οξεα και πρωτεϊνες του γονιδιου mhp3 του mycoplasma hyopneumoniae και χρησεις αυτων
Kalinna et al. Engineering and expression of a full length cDNA encoding Schistosoma japonicum paramyosin: purification of the recombinant protein and its recognition by infected patient sera
HUP9802238A2 (hu) Fokozott immunizáló képességű módosított polipeptidek
ZA200602107B (en) Piroplasmid vaccine
EP1090995A3 (en) Mycoplasma hyopneumoniae antigen MHP3, gene encoding it and uses thereof
CA2284110A1 (en) An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
DK1146889T3 (da) Identifikation af specifikke differentielt udtrykte mycobakterielle antigener og medicinsk anvendelse af Mycobakteriumproteinerne Rv0068 og Rv3407
Soltani et al. Cloning, nucleotide sequencing and bioinformatics study of NcSRS2 gene, an immunogen from Iranian isolate of Neospora caninum
HUP0200832A2 (hu) Babesia canis oltóanyag

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees